semaglutide breakouts GLP-1 Agonists Not Linked to the Development of Acne Dermatologic findings associated with semaglutide

31 Leong, G.S

Tirzepatide activates two pathways GLP-1 and GIP and in clinical trials produced greater average weight loss, particularly for patients at higher BMIs or with significant insulin resistance

DNA damage and apoptosis in mononuclear cells from glucose-6-phosphate dehydrogenase-deficient patients (G6PD Aachen variant) after UV irradiation

it should never be one-size-fits-all

Human MCT Trial: Real-World Energy and Muscle Outcomes Ezaki & Abe (2023) in Frontiers in Nutrition a combined analysis of 3 clinical trials found that 6g/day of C8/C10 MCTs over 3 months improved grip strength, walking speed, and muscle mass in frail older adults (mean age 85)

"Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157." Current Pharmaceutical Design , 24(18), 19902001